Taken together, these results suggest that TH1L may play a vital role via the CCL20/NF‐κB signalling pathway in CRC proliferation and migration and may serve as a potential target for diagnosis and therapy of CRC. The gene discussed is NFKB1; the disease is colorectal carcinoma.